Purchase Order HT001416P1131

Award Date 6/6/16
Potential Completion Date 6/5/20
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The $70,940.00 contract is to provide unspecified products and services related to the agency's medical research and clinical testing programs. This award does not have a set-aside designation. Luminex has previously been issued task orders under various government-wide acquisition vehicles and has served as a subcontractor...
This $55,458.60 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Luminex Corporation, a manufacturer of biological testing technologies, to provide laboratory supplies. The contract does not have a set-aside designation. Luminex has previously received prime and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and National Institutes of Health, to deliver immunology...
This is a $30,868.00 firm fixed price purchase order contract awarded to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The contract is for LUMINEX200 IMMUNOASSAY products and services, with a period of performance through March 4, 2026. The award was made by the National Institute of Environmental Health Sciences, a civilian federal agency. Luminex has provided similar immunology, laboratory, and diagnostic products and services to...
The U.S. Defense Logistics Agency awarded a Firm Fixed Price delivery order contract worth $1,069 to Luminex Corp, a manufacturer of biological testing technologies. The contract is for the provision of LUMINEX 100/200 performance verification services. Luminex, which is a foreign-owned, for-profit organization, will deliver immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to support clinical testing programs and...
This is a firm fixed-price purchase order awarded to Luminex Corp by the Defense Health Agency, a component of the Department of Defense. The contract, valued at $40,092.00, is for base year gold preventative maintenance and service on an unspecified type of equipment. The contract has a period of performance through September 2026 and was awarded on September 22, 2023. This award is not associated with a set-aside or broader indefinite delivery vehicle. Luminex Corp is a foreign-owned,...
This is a $6,613.94 firm fixed-price purchase order awarded to Luminex Corp by a U.S. government agency. The contract is described as "DEOBLIGATE UNDELIVERED AMOUNT" and did not utilize a set-aside. Luminex Corp is a manufacturer of biological testing technologies, including multiplex diagnostic solutions, and has provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies. While Luminex...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The $7,150.00 order is for the provision of Luminex's 100/200 testing platform, which supports automated analysis of multiple biomarkers. This award falls under a larger indefinite delivery vehicle and is not set-aside. Luminex has a history of providing multiplex diagnostic solutions, assay kits, reagents,...
This is a $19,553.85 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Luminex Corp, a for-profit manufacturer of biological testing equipment and diagnostic solutions. The service level agreement contract is for the delivery of Luminex's proprietary multiplexing systems, assay kits, reagents, and related products to support clinical testing programs and biomedical research efforts across federal agencies....
This is a firm fixed-price purchase order awarded to Luminex Corp by the National Institute of Allergy and Infectious Diseases, a civilian agency, for the delivery of a cell analyzer valued at $15,279.02. The contract has an ultimate completion date of August 12, 2021. Luminex Corp is a manufacturer of biological testing technologies, including multiplex diagnostic solutions for clinical laboratories and life science research settings. The company frequently serves as a prime contractor for...
This is a $82,472 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs to Luminex Corp, a manufacturer of biological testing technologies. The contract is for the delivery of unspecified test kits, with a period of performance running through September 30, 2025. No set-aside designation is indicated. Luminex is a foreign-owned, for-profit organization that provides proprietary multiplexing platforms,...

This is a $60,188.00 firm fixed price purchase order awarded to Luminex Corp, a manufacturer of biological testing technologies, by the Defense Health Agency. The contract is not set aside and was awarded on June 6, 2016 with a completion date of June 5, 2020. Luminex has provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance services, and diagnostic testing products to various federal agencies including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and military services. This award is likely part of Luminex's established government contracts and blanket purchase agreements that streamline procurement of their proprietary platforms, reagents, and testing products.

Generated 3/29/25, 9:48 AM